IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
26 hedge funds and large institutions have $11.4M invested in Insight Molecular Diagnostics Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.
Holders
26
Holders Change
-4
Holders Change %
-13.33%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
8
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$615K |
| 2 |
AIC
2
AWM Investment Company
New York
|
$1.87M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$620K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$8.32K |
| 5 |
5
Renaissance Technologies
New York
|
$32K |
